Web11 Apr 2024 · ATOS Stock Overview Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing medicines in the areas of unmet … Web9 May 2024 · SEATTLE, May 09, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to develop innovative proprietary medicines in oncology and...
Atossa Therapeutics NasdaqCM:ATOS Stock Report - Simply …
WebOver the last 12 months, Atossa Genetics's shares have ranged in value from as little as $0.5 up to $1.36. A popular way to gauge a stock's volatility is its "beta". Beta is a … WebAtossa Therapeutics Inc (US:ATOS) has 101 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 19,486,072 shares. showtime italy
3 Reasons to Love Atossa Therapeutics Stock Nasdaq
WebAtossa Therapeutics, Inc. (ATOS) Latest Stock News & Headlines - Yahoo Finance Watchlists My Portfolio Crypto Yahoo Finance Plus Videos U.S. markets closed S&P … WebHolder Shares Date reported % out Value; Vanguard Total Stock Market Index Fund: 3,779,376: 29 Sept 2024: 2.98%: 2,631,957: Vanguard Extended Market Index Fund Web24 Oct 2024 · Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company seeking to develop innovative medicines in areas of significant unmet medical need in oncology with a current focus on breast cancer. For more information, please visit www.atossatherapeutics.com. Forward Looking Statements showtime jake paul vs tyron woodley